BetaPark – Term of the Month
What is BetaPark? BetaPark is a translational EEG biomarker recorded…
ASSR – Term of the Month
Auditory Steady-State Response (ASSR) is a translational EEG biomarker of…
HPD – Term of the Month
What are HPD? Mesio-temporal lobe epilepsy (MTLE) represents one of…
SWD – Term of the month
What are SWD? Patients with Absence Epilepsy show generalized, non-convulsive…
SWISS BIOTECH DAY 2019
Did you know that Electro-Encephalography (EEG, EPhys) has the power…
AEDD TRIALS – SynapCell, Key Player in Epilepsy
As a key player in Epilepsy, SynapCell will participate to…
AD/PD 2019 – Phase-amplitude coupling as a new biomarker of PD
Phase-amplitude coupling as a new biomarker of PDDiscover the science…
PAC – Term of the month
Phase-amplitude coupling can help study the interactions between neuronal oscillations.…
ASENT 2019 – From EEG signatures to predictive biomarkers
From EEG signatures to predictive biomarkers. Learn how to accelerate…
ERP – Term of the month
Word of the month : ERPs Event-related potentials are defined…
2019 – Happy New Discoveries !
We hope you had a great year! 2018 has kept…
Cavion and SynapCell present significant seizure-suppressing outcomes using the GAERS rat
Cavion’s T-Type Calcium Channel Modulator CX-8998 is Superior to Current…
Pfizer and SynapCell present major preclinical efficacy results using the GAERS
Absence epilepsy is a form of epileptic syndrome where patients show generalized…
SynapCell at the Michael J. FOX Parkinson’s disease conference
Meet Corinne Roucard Oct 25 at The Michael J. Fox…
BioJapan 2018, Yokohama
BioJapan is approaching! Our team is heading to Osaka on…
SFN 2018 – Major milestones achieved
We’ll exhibit at SfN 2018 in San Diego! 2018 has…
BIO2018, Boston
Meet the team and discover how we help solve uncertainty…
Meet SynapCell at EILAT XIV
SynapCell will participate to the 14th EILAT Conference on New Antiepileptic Drugs…
SynapCell et Neuroservice lancent une offre commune
Baptisée NeurOsyn-alliance, cette solution unique et innovante, fruit d’une étroite…
Les nouvelles perspectives de SynapCell
Installée dans de nouveaux locaux où sont réunies toutes ses…
Today is the international Epilepsy Day
Today is the International Epilepsy Day. #EPILEPSYDAY An epileptic disorder…
Neurosyn. Unveiled.
Neuroservice and SynapCell are very pleased to announce the launch…
Neuroscience 2017
Plan to attend Neuroscience 2017 in DC this year? SynapCell…
A Word about AED Trials
ust back from Miami, USA where I had the chance…
AED TRIALS XIV
SynapCell to unveil unprecedented advances in Epilepsy at the Antiepileptic…
SynapCell at AD/PD 2017
Dear all, We are pleased to announce that we will…
SynapCell selected as key partner of the ETSP
SYNAPCELL RE-ESTABLISHES PARTNERSHIP WITH THE UNIVERSITY OF UTAH TO SCREEN…
Neuroscience 2016
Save the Date! SynapCell will attend the Neuroscience 2016 Meeting.…
MDS 2016 – Let’s meet in Berlin !
Our experts will present 2 Posters on the use of EEG…
EILAT XIII CONFERENCE: Attending ?
SynapCell will attend the 13th EILAT Conference on New Antiepileptic Drugs…
SynapCell’s Article about the MTLE Model published
We are delighted to share with you the publication of our…
NEUROSCIENCE 2015 – Let’s meet in Chicago !
Coming up in a month in Chicago, Neuroscience 2015 is the world’s…
A world about neuroscience 2015
A week is already gone since I got back from…
NEUROSCIENCE 2015 – Stop Guessing
Stop guessing; think outside the box with EEG! We can…
NEURINOX SYMPOSIUM 2015
SynapCell is involved in the funded EU Project NEURINOX. Together with…
28TH ECNP Congress
At the end of the summer, SynapCell is going to take part…
ADD SYMPOSIUM’S 2015
Two majors congresses for epilepsy drug discovery are taking place…
AED TRIALS XIII – 2015
Two majors congresses for epilepsy drug discovery are taking place…
SynapCell mandated by UCB to enhance its epilepsy drug discovery program
Synapcell to assess the potential of UCB’s candidate molecules in…